首页|蒽环类药物心脏毒性的中西药防治策略

蒽环类药物心脏毒性的中西药防治策略

扫码查看
蒽环类药物的心脏毒性对其临床使用造成极大限制,为探究蒽环类心脏毒性的规律及中西药防治策略,本文通过文献检索对蒽环类药物心脏毒性的发生机制和防治药物进行了归纳总结,其机制可分氧化应激、炎性反应、心肌细胞自噬以及DNA损伤4大类。防治药物西药以右丙亚胺、ACEI、ARB等为主,中药可分为单药、经方及中成药。在此基础上,对联合用药防治心脏毒性进行了讨论,介绍了西药、中药及中西药联合应用的理论依据及研究现状,结果表明其具有良好的可行性和安全性,可为临床上蒽环类化疗药物心脏毒性的防治策略研究提供参考。
Chinese and Western Medicine Control Strategies for Anthracycline Cardiotoxicity
Cardiac toxicity of anthracycline greatly limit its clinical use,to explore the rule of anthracycline cardiotoxicity and prevention and control strategies of Chinese and western medicine,this paper through the literature search mechanism and drugs is summarized,the mechanism can be divided into oxidative stress,inflammatory reaction,myocardial cell autophagy and DNA damage four categories,the prevention and treatment of western medicine to dc prosamine,ACEI,ARB is given priority to,Chinese medicine can be divided into single medicine,by prescription and proprietary Chinese medicine.On this basis,the combination drug is discussed to prevent cardiotoxicity,and the theoretical basis and research status of the combined application of western medicine,traditional Chinese medicine and Chinese and western medicine are introduced.The results show that it has good feasibility and safety,and can provide reference for the clinical treatment strategy of anthracycline chemotherapy drugs.

AnthracyclinesCardiotoxicityPrevention and control strategyWestern medicineTraditional Chinese medicineDrug combination

钱俊、张淑敏、仇慧鑫、刘思彤、邓雁如、舒乐新

展开 >

天津中医药大学中药学院 天津 301617

蒽环类药物 心脏毒性 防治策略 西药 中药 联合用药

2024

世界科学技术-中医药现代化
中科院科技政策与管理科学研究所,中国高技术产业发展促进会

世界科学技术-中医药现代化

CSTPCD北大核心
影响因子:1.175
ISSN:1674-3849
年,卷(期):2024.26(7)